Akron Children's Logo
Skip to main content
Close Tools Menu Icon

Operator:

330-543-1000

Questions or Referrals:
ASK CHILDREN‘S

Close Phone Menu Icon
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Efficacy of KL1333 in adult patients with primary mitochondrial disease

Full IRB Study Title:
An interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose, adaptive study of the efficacy of KL1333 in adult patients with primary mitochondrial disease

IRB Study ID: 2023-006

For complete details, please view the study on Clinicaltrials.gov

Study Sponsor:

Abliva AB

 We are currently recruiting

If you are interested in this study or have questions about your child's eligibility, please contact:

Josselyn Coppenger BSN, RN / 330-543-6164

Lead Investigator

Bruce H. Cohen

Bruce H. Cohen, MD, FAAN

Chair, NeuroDevelopmental Science Center; Philip H. Maynard Chair in NeuroDevelopmental Science Fund; Chairman, American Academy of Neurology Advocacy Committee; Pediatric Neurologist


Pediatric Brain Tumor ProgramPediatric NeurologyMitochondrial Center

More about this provider

Back to top of page

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.